Litcius/Paper detail

(2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS).

Radek Pudil, Vilém Danzig, Jiří Veselý, Filip Málek, Miloš Táborský, Lubomı́r Elbl, Aleš Linhart, Hana Skalická

2023Cor et Vasa10 citationsDOIOpen Access PDF

Abstract

Překlad zkráceného dokumentu připravený Českou kardiologickou společnostíLyon AR, López-Fernández T, Couch LS, Asteggiano R, Aznar MC, Bergler-Klein J, Boriani G, Cardinale D, Cordoba R, Cosyns B, Cutter DJ, de Azambuja E, de Boer RA, Dent SF, Farmakis D, Gevaert SA, Gorog DA, Herrmann J, Lenihan D, Moslehi J, Moura B, Salinger SS, Stephens R, Suter TM, Szmit S, Tamargo J, Thavendiranathan P, Tocchetti CG, van der Meer P, van der Pal HJH; ESC Scientific Document Group.

Topics & Concepts

MedicineInternal medicineOncologyLibrary scienceComputer scienceChemotherapy-induced cardiotoxicity and mitigationLung Cancer Diagnosis and TreatmentCardiac tumors and thrombi
(2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS). | Litcius